New England Journal of Medicine
-
June 8, 2022
Research probes cause of acute flaccid myelitis in children
Research that began at Vanderbilt University Medical Center has found evidence that a viral infection followed by a “robust” immune response is the cause of a polio-like paralyzing illness in children called acute flaccid myelitis (AFM). -
May 12, 2022
VUMC-led study finds Moderna COVID vaccine safe and effective for children
-
May 10, 2022
New study illustrates how much it would cost for cancer drugs covered under Medicare Part D
A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit. -
December 8, 2021
International study supports dupilumab for treatment of moderate-to-severe asthma in children
In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients. -
May 20, 2021
VUMC is pacesetter for national aspirin study
According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease. -
April 22, 2021
A young doctor wrote of a life-or-death moment caring for a patient. The New England Journal of Medicine published it as a graphic novel.
A terrifying tale from her first weekend on call. -
February 2, 2021
Study finds recommended ICU sedatives equally safe, effective
Sedative medications used in intensive care are associated with increased delirium, which is in turn connected with higher medical costs and greater risk of death and ICU-related dementia.